Schedule 13D ownership disclosure
Amneal Pharmaceuticals Inc
Security class unavailable · CUSIP: 03168L105
Event date: 2018-07-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-214792
- Form type
- SC 13D
- Filer
- Amneal Pharmaceuticals, Inc.
- CIK
- CIK 1723128
- Filed
- Jul 09, 2018
- Reporting period
- Jul 05, 2018
- Description
- Schedule 13D beneficial ownership